Companies & Industry »Company News»Company News Details
Company News Details

BSE   28 Jul 14 | 12:00 AM

1129.10 6.4 (0.57%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   28 Jul 14 | 12:00 AM

1126.45 -0.1 (-0.01%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,100.80 (2.57%)
1 Month : Rs 1,053.20 (7.21%)
1 Year : Rs 730.00 (54.67%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Hind. Unilever686.453.69
Sun Pharma.Inds.789.701.33
B H E L229.501.17
Wipro555.100.86
Dr Reddy`s Labs2,766.700.76

Online Portfolio

You can create Online Portfolio here using the below button.